Navigation Links
GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
Date:3/9/2009

PITTSBURGH, March 9 /PRNewswire/ -- In Kentucky, nearly one out of every two of the state's children are enrolled in Medicaid, but barely a quarter of the dentists accept the insurance; therefore families on Medicaid are left with few options when it comes to seeing a dentist or receiving dental care.

In an effort to assist, GlaxoSmithKline Consumer Healthcare, manufacturer of Aquafresh(R) and Sensodyne(R), has donated 10,000 toothbrushes and 30,000 tubes of toothpaste. Polident(R), another brand in GSK's oral care portfolio, has also contributed a generous amount of Polident Partials for use in cleaning partial dentures as well as Polident Dentu-Gel Denture Toothpaste.

According to Colin Mackenzie, Vice President of Oral Care at GlaxoSmithKline Consumer Healthcare, "This donation of Aquafresh, Sensodyne, and Polident is one example of how we can support GSK's commitment of providing greater access to quality products and building trust in the community."

Dr. Edwin Smith, D.M.D. and his team at Kids First Dental Care are working to address the serious gap for children's oral care in Kentucky which was brought to the national spotlight during a special entitled "A Hidden America: Children of the Mountains," which aired on ABC's 20'20 last month.

Dr. Smith says he is thrilled by GlaxoSmithKline's donation, "This donation from GSK is one of the most generous we have received. These oral care products will be put to good use because we can actually get them directly into the hands of the children who need them the most."

Kids First Dental Care was formed in 2004 when Dr. Smith collaborated with local school personnel to explore ways to provide dental care to school children. Agreeing that the best way to gain access for children was to take the care directly to them in school, he purchased a used CAT scan trailer and outfitted it with used dental equipment. This was the beginning of Kids First Dental Care, a unique school-based dental program designed to improve access to dental care, particularly among low-income children.

GlaxoSmithKline Consumer Healthcare has made a pledge to provide additional support to Kids First Dental Care, further assisting them in their efforts to provide access to comprehensive dental treatment for the children in Kentucky.

To learn more about Kids First Dental Care, visit their website at www.kidsfirstdental.org

About GlaxoSmithKline Consumer Healthcare

GlaxoSmithKline Consumer Healthcare is one of the world's largest over-the-counter consumer healthcare companies. Its more than 30 well-known brands include the products Goody's(R), Nicorette(R), NicoDerm(R) CQ(R), Commit(R), Abreva(R), Aquafresh(R), Sensodyne(R) and Tums(R), trademarks owned by and /or licensed to GlaxoSmithKline Group of Companies.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and consumer healthcare companies. GlaxoSmithKline is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

    Contact:     Laurie Garvey
                 412-200-3390
                 Laurie.L.Garvey@gsk.com

                 Sarah Ann Harris, GolinHarris
                 312-729-4285
                 SHarris@golinharris.com


'/>"/>
SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
2. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
3. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
4. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
5. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
6. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
7. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
8. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
9. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
10. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
11. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/30/2016)... ... April 30, 2016 , ... Create an ... users can distort and manipulate three-dimensional shapes with ease all within Apple ... point, lines, polygons, polygon texture animation, opacity texture animation, overall shape texture displacement, ...
(Date:4/30/2016)... , ... April 30, 2016 , ... ... announced RANKED Health , a program to critically evaluate and rank health-focused ... of the program is to provide independent, unbiased and accurate information to help ...
(Date:4/30/2016)... ... April 30, 2016 , ... Dr. Trevor ... of EMED, today signed a multifaceted agreement which will allow for the research ... University Department of Natural and Applied Sciences, Allied Health and Nursing will work ...
(Date:4/30/2016)... Rosa, CA (PRWEB) , ... April 30, 2016 , ... “Aging well is a challenge for all of us, but ... NCMA’s Dr. Parul T. Kohli . “Research is showing more and more that there ... risk of disease and disability as we age.” Top priorities Dr. Kohli’s recommends for her patients ...
(Date:4/29/2016)... Miami, FL (PRWEB) , ... April 30, 2016 ... ... manufacturer and engineer of patented products, announces the Pick Up Springboard, an automotive ... SUV and Light Truck Manufacturing industry is worth $162 billion," says Scott Cooper, ...
Breaking Medicine News(10 mins):
(Date:4/27/2016)... , April 27, 2016 Shire plc ... Jeff Poulton , Chief Financial Officer, will present at the ... Boston, MA on Wednesday, May 04, 2016, 10:00 ... will be available on the Presentations and Webcasts section of ... of the webcast will be available on this same website ...
(Date:4/27/2016)... 27, 2016 Oasmia Pharmaceutical ... of a new generation of drugs within human ... results for Paclical/Apealea in the Phase III study ... epithelial ovarian cancer. These preliminary results showed non-inferiority ... with carboplatin versus Taxol in combination with carboplatin. ...
(Date:4/27/2016)... 2016 The global  gamma ... billion by 2022, according to a new report ... towards a healthy lifestyle is expected to drive ...      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) , ... health treatment expenditure has urged consumers to switch ...
Breaking Medicine Technology: